Hemodynamic studies in primary myocardial disease.
D000293:Adolescent; D000328:Adult; D000686:Amyloidosis / Q000503:physiopathology*; D000792:Angiography; D001024:Aortic Valve Stenosis / Q000503:physiopathology*; D001602:Beriberi / Q000503:physiopathology*; D001794:Blood Pressure / Q000187:drug effects*; D002277:Carcinoma / Q000503:physiopathology; D006328:Cardiac Catheterization; D002302:Cardiac Output; D003937:Diagnosis, Differential; D004562:Electrocardiography; D005080:Exercise Test; D005260:Female; D006325:Heart Atria / Q000503:physiopathology; D006331:Heart Diseases / Q000503:physiopathology*; D006338:Heart Neoplasms / Q000503:physiopathology*; D006352:Heart Ventricles / Q000503:physiopathology; D006801:Humans; D006984:Hypertrophy / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D009136:Muscular Dystrophies / Q000503:physiopathology*; D009205:Myocarditis / Q000175:diagnosis*; D009362:Neoplasm Metastasis / Q000503:physiopathology; D010494:Pericarditis, Constrictive / Q000175:diagnosis*; D011433:Propranolol / Q000494:pharmacology; D012507:Sarcoidosis / Q000503:physiopathology*; D012595:Scleroderma, Systemic / Q000503:physiopathology*; D014655:Vascular Resistance
D011433:Propranolol